Low polymorphonuclear cell degranulation during citrate anticoagulation: A comparison between citrate and heparin dialysis

Nephrology Dialysis Transplantation

Volumn 12, Issue 7, 1997, Pages 1387-1393

  Bos, J C ^a   Grooteman, M P C ^a   Van Houte, A J ^a   Schoorl, M ^a   Van Limbeek, J ^b   Nube M J ^a  

^a Location Alkmaar   (Netherlands)

^b Municipal Medical and Health Centre   (Netherlands)

Author keywords

Bio incompatibility; Citrate; Degranulation; Haemodialysis; Heparin; PMN

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ION; CITRIC ACID; COMPLEMENT; HEPARIN; LACTOFERRIN; MYELOPEROXIDASE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BIOCOMPATIBILITY; CALCIUM BLOOD LEVEL; CELL ACTIVATION; CELL ADHESION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLEMENT ACTIVATION; DEGRANULATION; FEMALE; HEMODIALYSIS; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MALE; NEUTROPENIA; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CALCIUM; CELL DEGRANULATION; CITRIC ACID; FEMALE; HEPARIN; HUMANS; LACTOFERRIN; MALE; MIDDLE AGED; NEUTROPHILS; PEROXIDASE; RENAL DIALYSIS;

EID: 0030789993     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.7.1387     Document Type: Article

References (46)

1. Falkenhagen D, Mitzner S, Stange J, Klinkman H. Biocompatibility: methodology and evaluation. Contrib Nephrol 1993; 103: 34-54
2. Kaplow LS, Goffinet JA. Profound neutropenia during the early phase of haemodialysis. JAMA 1968; 203: 133-135
3. de Jonge FAA, Kalkman CJ, Daha MR, Nubé MJ. Hemodialysis biocompatibility: Dialyzer, dialysate and patient dependent responses. ISAO press 1987; 308: 48-53
4. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS. Hemodealysis leukopenia, pulmonary leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 1977; 59: 879-888
5. Innes A, Farrell AM, Burden RP, Morgan AG, Powell RJ. Complement activation by cellulosic dialysis membranes. J Clin Pathol 1994; 47: 155-158
6. Hakim RM, Fearon DT, Lazarus M. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26: 194-200
7. 111Indium-labeled granulocytes into the lung during haemodialysis. J Nephrol 1990; 4: 235-239
8. Tielemans CL, Delville JPC, Husson CP et al. Adhesion molecules and leukocyte common antigen on monocytes and granulocytes during hemodialysis. Clin Nephrol 1993; 39: 158-163
9. Falkenhagen D, Brown GS, Thomaneck U et al. Behaviour of white blood cells and the complement system. Nephrol Dial Transplant 1993; 8 [Suppl 2]: 8-14
10. Kolb G, Höffken H, Müller T, Havemann K, Lange H. Kinetics of pulmonary leukocyte sequestration with different membranetypes. Int J Artif Organs 1990; 13: 729-36
11. Hörl, Riegel W, Steinhauwer HB et al. Granulocyte activation during hemodialysis. Clin Nephrol 1986; 26 [Suppl. 1]: 30-34
12. Hällgren R, Venge P, Danielson BG. Neutrophil and eosinophil degranulation during hemodialysis are mediated by the dialysis membrane. Nephron 1982; 32: 329-334
13. 2-microglobulin and granulocyte elastase. Nephrol Dial Transplant 1993; 8 [Suppl. 2]: 20-24
14. Spitznagel JK, Dalldorf FG, Martin LE. Character of azurophil and specific granules purified from human polymorphonuclear leukocytes. Lab Invest 1974; 30: 774-785
15. Haag Weber M, Mai B, Cohen G, Hörl WH. GIP and DIP: a new view of uraemic toxicity. Nephrol Dial Transplant 1994; 9: 346-347
16. Heidland A, Hörl WH, Heller N, Heine H, Neumann S, Heidbreder E. Proteolytic enzymes and catabolism: Enhanced release of granulocyte proteinases in uremic intoxication and during hemodialysis. Kidney Int 1983; 24 [Suppl. 16]: 27-36
17. Hörl WH, Schaefer RM, Heidland A. Evidence for the participation of granulocyte proteinases on intradialytic catabolism. Clin Nephrol 1984; 21: 314-322
18. Cheung AK, Parker CJ, Hohnholt M. Soluble complement receptor type 1 inhibits complement activation induced by hemodialysis membranes in vitro. Kidney Int 1994; 46: 1680-1687
19. Hörl WH, Steinhauer HB, Riegel W, Schollmeyer P, Schäfer RM, Heidland A. Effect of different dialyzer membranes on plasma levels of granulocyte elastase. Kidney Int 1988; 33 [Suppl. 24]: 90-91
20. Kolb G, Nolting C, Eckle I, Müller T, Lange H, Havemann K. The role of membrane contact in hemodialysis-induced granulocyte activation. Nephron 1991; 64-68
21. Weissmann G, Zurier RB, Hoffstein S. Leukocytic proteases and their immunologic release of lysosomal enzymes. Am J Path 1972; 68: 539-559
22. Woffindin C, Hoenich NA, Matthews JNS. Cellulose-based haemodialysis membranes: biocompatibility and functional performance compared. Nephrol Dial Transplant 1992; 7: 340-345
23. Böhler J, Donauer J, Birmelin M, Schollmeyer PJ, Hörl WH. Mediators of complement-independent granulocyte activation during haemodialysis: role of calcium, prostaglandins, and leukotrienes. Nephrol Dial Transplant 1993; 8: 1359-1365
24. Tetta C, Camussi G, Segoloni G, Vercellone A. Direct interaction between polymorphoneutrophils (PMN) and dialysis membranes: role of the electrical charges. Kidney Int 1986; 29: 609 (absract)
25. Albert B, Bray D, Lewis J, Roberts K, Watson JD. Molecular biology of the cell. Garland Publishing Inc, New York, 1983; 483: 739-765
26. 2 integrins are required for neutrophil degranulation induced by hemodialysis membranes. Kidney Int 1993; 43: 649-660
27. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Eng J Med 1983; 308: 258-261
28. Van der Meulen J, Janssen MJFM, Langendijk PNJ, Bouman AA, Oe PL. Citrate anticoagulation and dialysate with reduced buffer content in chronic haemodialysis. Clin Nephrol 1992; 37: 36-41
29. Janssen MJFM, Huijgens PC, Bouman AA, Oe PL, van der Meulen J. Citrate anticoagulation and divalent cations in haemodialysis. Blood Purif 1994; 12: 308-316
30. Janssen MJFM, Huijgens PC, Bouman AA, Oe PL, Donker AJM, van der Meulen J. Citrate versus heparin anticoagulation in chronic haemodialysis patients. Nephrol Dial Tansplant 1993; 8: 1228-1233
31. Lobatto S, Daha MR, Voetman AA et al. Clearance of soluble aggregates of human immunoglobulin G in healthy vounteers and chimpansees. Clin Exp Immunol 1987; 69: 133-141
32. Miltenburg AMM, Van Laar JM, De Kuiper R, Daha MR, Breedveld FC. T-cells cloned from rheumatoid synovial membrane functionally represent the TH1 subject. Scand J Immunol 1992; 35: 603-610
33. 1-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119 (2): 159-168
34. Bölher J, Schollmeyer P, Dressel B, Dobos G, Hörl W. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation. J Am Soc Nephrol 1996; 7: 234-241
35. Martin-Malo A, Castillo D, Castro M et al. Biocompatibility of dialysis membranes: A comparative study. Nephrol Dial Transplant 1991; [Suppl. 2]: 55-58
36. Grooteman MPC, Nubé MJ, van Limbeek J, van Houte AJ, Daha MR, van Geelen JA. Biocompatibility and performance of a cellulosic and a synthetic high flux dialyzer: A randomized crossover comparison between cellulose triacetate and polysulphon. ASAIO J 1995; 41: 215-220
37. Kuijpers TW, Tool ATJ, van der Scoot CE et al. Membrane surface antigen expression on neutrophils: a reappraisal of the use of surface markers for neutrophil activation. Blood 1991; 78: 1105-1111
38. Böhler J, Reetze-Bonorden P, Frommherz K, Schollmeyer P, Hörl WH. Granulocyte activation during hemodialysis and plasmapheresis: comparison of PMMA with Cuprophan and Polyethylene. Blood Purif Perspec II, ICAIOT Press, 1992; 320: 213-216
39. 2+ not complement is the key trigger for neutrophil degranulation during hemodialysis. Nephrol Dial Transplant 1992; 7: 721 (abstract)
40. Riegel W, Spillner G, Schlosser V, Hörl WH. Nifedipine inhibits granulocyte activation during cardiopulmonary bypass. Klin Wochenschr 1987; 65: 581
41. Johnson RJ, Burhop kE, van Epps DE. Infusion of ovine C5a into sheep mimics the inflammatory response of hemodialysis. J Lab Clin Med 1996; 127(5): 456-469
42. Cheung AK, Faezi-Jenkin B, Leypoldt JK. Effect of thrombosis on complement activation and neutrophil degranulation during in vitro hemodialysis. J Am Soc Nephrol 1994; 5: 110-115
43. Shastri KA, Logue GL, Stern MP et al. Neutrophil lactoferrin release during open heart surgery is unrelated to complement activation. ASAIO J 1994; 40: 56-61
44. Léculier C, Couprie N, Leitienne PAP, Francina A, Richard M. The effects of high molecular weight- and low molecular weight-heparins on Superoxide ion production and degranulation by human polymorphonuclear leukocytes. Thromb Res 1993; 69: 519-531
45. Faymonville ME, Pincemail J, Duchateau J et al. Myeloperoxidase and elastase as markers of leukocyte activation during cardio-pulmonary bypass in humans. J Thorac Cardiovasc Surg 1991; 102: 309-317
46. Bazzoni G, Nuñez AB, Mascellani G, Bianchini P, Dejana E, Del Maschio A. Effect of heparin, dermatan sulfate, and related oligo-derivates on human polymorphonuclear leukocyte functions. J Lab Clin Med 1992; 121: 268-275